NovoCure (NVCR) Q3 2026 Earnings

23JulConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.62
-0.46
-0.29
-0.13

Details

Expected EPS
-0.331533
Actual EPS
-0.13
Surprise EPS
0.2
Surprise Percent
+60.79%

Description

NovoCure (NVCR) has reported earnings of -0.13 per share for Q3 2026.

0 Comments

Share your thoughts